| 000 | 01510 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516111903.0 | ||
| 264 | 0 | _c20130131 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2012.06.046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVitale, A | |
| 245 | 0 | 0 |
_aSorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cSep 2012 |
||
| 300 |
_a1989-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzenesulfonates _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aBoccagni, P | |
| 700 | 1 | _aKertusha, X | |
| 700 | 1 | _aZanus, G | |
| 700 | 1 | _aD'Amico, F | |
| 700 | 1 | _aLodo, E | |
| 700 | 1 | _aPastorelli, D | |
| 700 | 1 | _aRamirez Morales, R | |
| 700 | 1 | _aLombardi, G | |
| 700 | 1 | _aSenzolo, M | |
| 700 | 1 | _aBurra, P | |
| 700 | 1 | _aCillo, U | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 44 _gno. 7 _gp. 1989-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2012.06.046 _zAvailable from publisher's website |
| 999 |
_c22101996 _d22101996 |
||